Major cancer registry launches to track Real-World blood cancer treatments

NCT ID NCT06976918

Not yet recruiting Knowledge-focused Sponsor: iOMEDICO AG Source: ClinicalTrials.gov ↗

Summary

This study is creating a national registry to track how 200 patients with myelofibrosis (a rare bone marrow cancer) and anemia are treated in real-world German clinics. It will follow patients for up to three years to document which treatment sequences doctors use, how patients respond, and how the disease affects their quality of life. The goal is to gather knowledge to improve future care, not to test a new drug.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Multiple sites all over Germany

    Multiple Locations, Germany

Conditions

Explore the condition pages connected to this study.